Given the activation of NFκB signaling in astroglial cultures stimulated with NMO IgG, we sought to identify pharmacological inhibitors that would block such signaling and provide insight into the underlying mechanisms of activation. This evidence concerns the gene NFKB1 and neuromyelitis optica.